Germany
Japan
United Kingdom
China
MAP2K2 (Myc-DDK-tagged)-Human mitogen-activated protein kinase kinase 2 (MAP2K2)
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
Products
View as table Download
Recombinant protein of human mitogen-activated protein kinase kinase 2 (MAP2K2)
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
Special Offer: Get a 20% discount on this product. Use code: "MVPro20".
Map2k2 (Myc-DDK-tagged) - Mouse mitogen-activated protein kinase kinase 2 (Map2k2)
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
Lenti ORF clone of Human mitogen-activated protein kinase kinase 2 (MAP2K2), mGFP tagged
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
MAP2K2 (GFP-tagged) - Human mitogen-activated protein kinase kinase 2 (MAP2K2)
| Vector | pCMV6-AC-GFP |
| Tag | TurboGFP |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
MAP2K2 (untagged)-Human mitogen-activated protein kinase kinase 2 (MAP2K2)
| Vector | pCMV6-XL5 |
| Tag | Tag Free |
| Mammalian Cell Selection | None |
Lenti ORF clone of Human mitogen-activated protein kinase kinase 2 (MAP2K2), Myc-DDK-tagged
| Vector | pLenti-C-Myc-DDK |
| Tag | Myc-DDK |
| Mammalian Cell Selection | None |
- LentiORF®
MAP2K2 (untagged)-Kinase deficient mutant (K101M) of Human mitogen-activated protein kinase kinase 2 (MAP2K2)
| Vector | pCMV6-XL4 |
| Tag | Tag Free |
| Mammalian Cell Selection | None |
MAP2K2 HEK293T cell transient overexpression lysate (as WB positive control)
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
| Applications | WB |
MAP2K2 (Human) - 3 unique 27mer siRNA duplexes - 2 nmol each
| Purity | HPLC purified |
| Number of Transfections | Approximately 330 transfections/2nmol in 24-well plate under optimized conditions (final conc. 10 nM). |
Special offer: Get $100/€100 off this product. Use code: SR100
SR321447 is the updated version of SR303762.
Rabbit Polyclonal MEK2 Antibody
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against A synthesized peptide derived from human MEK2 |
Rabbit Polyclonal MEK2 (Thr394) Antibody (Phospho-specific)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against A synthesized peptide derived from human MEK2 around the phosphorylation site of Threonine 394 |
| Modifications | Phospho-specific |
MAP2K2 - Human, 4 unique 29mer shRNA constructs in retroviral RFP vector
| Format | Retroviral plasmids |
| Vector | pRFP-C-RS |
| E. coli Selection | Chloramphenicol |
| Mammalian Cell Selection | Puromycin |
MAP2K2 - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector
| Format | Lentiviral plasmids |
| Vector | pGFP-C-shLenti |
| E. coli Selection | Chloramphenicol |
| Mammalian Cell Selection | Puromycin |
Anti-MAP2K2 Rabbit Polyclonal Antibody
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Synthetic peptide corresponding to a region derived from 20-34 amino acids of Human mitogen-activated protein kinase kinase 2 |
Active filters
Target Symbol
- MAP2K2
Availabilities
- In Stock
Filter by
Species
Reactivities
Antibody Hosts
Clonalities
Conjugates
Knockout (KO) Validation
Expression Hosts
Lentivirus
Vectors
Modifications
QC Levels
Mammalian Cell Selection
Families
Pathways
- Acute myeloid leukemia (20)
- B cell receptor signaling pathway (20)
- Bladder cancer (20)
- Chronic myeloid leukemia (20)
- Endometrial cancer (20)
- ErbB signaling pathway (20)
- Fc epsilon RI signaling pathway (20)
- Gap junction (20)
- Glioma (20)
- GnRH signaling pathway (20)
- Insulin signaling pathway (20)
- Long-term depression (20)
- Long-term potentiation (20)
- MAPK signaling pathway (20)
- Melanogenesis (20)
- Melanoma (20)
- Natural killer cell mediated cytotoxicity (20)
- Neurotrophin signaling pathway (20)
- Non-small cell lung cancer (20)
- Pathways in cancer (20)
- Prion diseases (20)
- Prostate cancer (20)
- Regulation of actin cytoskeleton (20)
- Renal cell carcinoma (20)
- T cell receptor signaling pathway (20)
- Thyroid cancer (20)
- Toll-like receptor signaling pathway (20)
- VEGF signaling pathway (20)
- Vascular smooth muscle contraction (20)